[Frequency and mode of use of testing for HIV infection in women hospitalized for childbirth]

Minerva Ginecol. 1995 Oct;47(10):439-45.
[Article in Italian]

Abstract

Objective: To assess the use of HIV testing "because of pregnancy".

Design: Cross-sectional study.

Patients: Parturients admitted to the obstetric divisions of a public hospital located in Rome (February-April 1994).

Intervention: Standardized interview during post test counseling. OUT-COMES: Frequency and characteristics of HIV testing "because of pregnancy" and women's know ledge on HIV sexual and vertical transmission.

Results: Among the 506 women admitted all consented to be tested and 3 were found HIV seropositive (0.6%). A total of 239 (47%) unselected parturients were interviewed; the remaining differ only for a lower rate of cesarean delivery (13% vs 54%). Of the interviewed, 140 (58%) had been already tested for HIV infection, 91 (38%) during the current pregnancy according to gynaecologist's prescription (79.87%) and without counseling (55.60%) or ascertained risk factors (82.90%); 40% had been tested after the first trimester of pregnancy. Rate of vertical transmission was estimated higher than 50% in 147 cases; 150 women knew the "window period" but less than half estimated it correctly.

Conclusions: The study showed a unsatisfactory use of HIV testing "because of pregnancy" and suggests the need for implementing in Italy information campaigns targeted both to women and gynecologists.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cross-Sectional Studies
  • Female
  • HIV Infections / diagnosis*
  • HIV Infections / drug therapy
  • HIV Infections / transmission
  • HIV Seropositivity / epidemiology*
  • Hospitals, Maternity
  • Humans
  • Pregnancy
  • Pregnancy Complications, Infectious / diagnosis*
  • Pregnancy Complications, Infectious / drug therapy
  • Pregnancy Complications, Infectious / virology
  • Rome / epidemiology
  • Zidovudine / therapeutic use*

Substances

  • Zidovudine